Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Supplement—December 2017
SUPPLEMENT ISSUE
Global Health Security Supplement
Detect

Global Disease Detection—Achievements in Applied Public Health Research, Capacity Building, and Public Health Diplomacy, 2001–2016

Carol Y. RaoComments to Author , Grace W. Goryoka, Olga L. Henao, Kevin R. Clarke, Stephanie J. Salyer, and Joel M. Montgomery
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.Y. Rao, G.W. Goryoka, O.L. Henao, K.R. Clarke, S.J. Salyer, J.M. Montgomery); Emory University, Atlanta (G.W. Goryoka)

Main Article

Table 3

Selected ongoing projects presented at the Global Disease Detection Program annual science meeting, by country and activity type assessed, June 2016, Atlanta, Georgia, USA*

Country Title of presentation Activity type
PHR S L PHI CB
Bangladesh Ensuring infection control is feasible and acceptable: identifying high-intensity interventions for Nipah-like illness and low-intensity interventions for routine use in Bangladesh X     X X
Making the case for rotavirus vaccination in Bangladesh: surveillance impacting public health interventions X   X X  
Spatial heterogeneity for dengue risk in Bangladesh: significance for other arthropodborne infections such as Zika
 X
  
 X
 X
  
China Verification of patients reported as central line–associated bloodstream infections (CLABSI) in a healthcare-associated infections surveillance system evaluation in Beijing X     X  
Risk factors for Vibrio parahaemolyticus infection in a southern coastal region in China
 X
  
  
 X
  
Egypt National surveillance of healthcare-associated infections and antimicrobial resistance in Egypt   X X X  
Overview of GDD Egypt’s population-based syndromic surveillance—Damanhur, Egypt, 2009–2016 X X X X  
Rickettsia typhi as an underrecognized cause of acute undifferentiated febrile illness—Damanhour, Egypt, 2010–2014
 X
  
  
 X
  
Georgia Bloodborne disease prevalence in the blood supply, Georgia, 2012–2014 X     X  
Hepatitis C elimination in Georgia: a one-of-a-kind program providing a golden opportunity to strengthen public health systems
 X
  
 X
 X
  
Guatemala Influenza-like illness and influenza vaccination during pregnancy in Quetzaltenango, Guatemala X X X X  
Participatory development of a congenital Chagas disease screening strategy after the vector control attack phase in Guatemala
 X
  
 X
 X
  
India Acute encephalitis syndrome in Assam, India: importance of Japanese encephalitis in the adult population, 2014–2015 X   X X  
Redrawing the boundaries of Kyasanur Forest Disease (KFD) in India: early results of GHSA-supported acute febrile illness surveillance
 X
  
 X
 X
  
Kazakhstan Strengthening the capacity of the Republic of Uzbekistan to combat antimicrobial resistance   X   X  
Implementation of the CCHF surveillance enhancement activities in Kazakhstan, 2012–2015
  
  
  
 X
 X
Kenya Epidemiology of brucellosis and MERS-CoV in linked human and animal populations in Kenya X   X X  
Indirect effects of 10-valent pneumococcal conjugate vaccine (PCV10) against adult pneumococcal pneumonia in rural western Kenya
 X
 X
 X
 X
  
South Africa Application of a simple differential diagnostic tool for solving febrile, neurologic and heamoragic fever cases in Southern Africa     X X  
Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003–2012: utility of laboratory-based information
 X
  
  
 X
  
Thailand Spotted fever group, typhus group rickettsioses and Sennetsu neorickettsiosis in rural Thailand X   X X  
Enhanced surveillance for severe pneumonia, Thailand 2010–2014   X X X  
Epidemiology and antimicrobial resistance of invasive salmonellosis, rural Thailand, 2006–2014
 X
  
 X
 X
  
No. presentations by activity type 18 6 15 23 2

*CB, technical capacity building; CCHF, Crimean-Congo hemorrhagic fever; GDD, Global Disease Detection; GHSA, Global Health Security Agenda; L, laboratory; MERS-CoV, Middle Eastern respiratory syndrome coronavirus; PHI, public health informatics; PHR, applied public health research; S, surveillance.

Main Article

Page created: November 20, 2017
Page updated: November 20, 2017
Page reviewed: November 20, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external